8-K: Amesite Reports 69% QoQ Revenue Surge, Eyes AI-Powered EMR

Amesite Inc. announced a 69% quarter-over-quarter revenue increase in Q2 2026, alongside reduced spending and plans to launch an AI-powered Electronic Medical Record platform by 2026.

Summary

• Amesite Inc. reported a 69% quarter-over-quarter (QoQ) revenue increase in Q2 2026, following an 82% QoQ increase in the prior quarter.
• Operating expenses were simultaneously reduced, demonstrating operational discipline and efficiency.
• The company is expanding its customer base and offerings within the post-acute healthcare segment across the U.S.
• Amesite plans to launch what it believes will be the industry's first AI-powered Electronic Medical Record (EMR) platform for post-acute care by 2026.
• Customer feedback for the NurseMagic™ product family has been excellent, with users reporting transformative changes in staff efficiency and documentation time.
• NurseMagic™ reduces typical documentation tasks from 20 minutes to 20 seconds, representing a 95% reduction in time.
• The platform is HIPAA compliant, secure, and available across iOS, Google Play, and web platforms, supporting over 100 professions in 50 states and 21 countries.
• As of September 30, 2025, Amesite had nearly $2 million in cash on hand, zero debt, and an estimated burn rate of nearly a year.
• Total revenue since inception is approximately $2.7 million, with 4.6 million shares outstanding and a float of 3.2 million shares.
• The company aims for profitability with fewer than 10,000 total B2C plus B2B users, with current average B2B pipeline deals at around 600 users.

Sentiment

Score: 8

Explanation: The filing presents a very positive outlook with strong revenue growth, reduced expenses, positive customer feedback, and clear strategic plans for an innovative AI-powered EMR. The financial health (zero debt, cash on hand) and management's personal investment further bolster confidence. Risks are acknowledged but not highlighted as immediate concerns.

Positives

• Achieved a significant 69% QoQ revenue increase in Q2 2026, demonstrating strong growth momentum.
• Successfully reduced operating expenses while increasing revenue, indicating improved operational efficiency.
• Received excellent product reviews and high customer satisfaction, leading to increased adoption in post-acute healthcare.
• NurseMagic™ significantly cuts documentation time by 95%, from 20 minutes to 20 seconds, enhancing healthcare worker productivity.
• The company has zero debt and nearly $2 million in cash on hand as of September 30, 2025, providing financial stability.
• Management and board members have demonstrated high conviction through personal investments in the company's $3 million raise in January 2025.
• The NurseMagic™ platform is HIPAA compliant, secure, and built on a robust AI-forward infrastructure, supporting rapid development and delivery of new capabilities (5-15 per week).
• Strong brand reach with nearly 50,000 social media followers and over a million accounts reached in the last 90 days.

Risks

• Actual results could differ materially from forward-looking statements due to various risks and uncertainties.
• The company's ability to achieve profitability depends on reaching a target of fewer than 10,000 total B2C plus B2B users, which is not guaranteed.
• Reliance on the successful development and market acceptance of the AI-powered EMR platform for post-acute care.
• Competition in the rapidly evolving AI and healthcare technology markets.

Future Outlook

Amesite anticipates continued rapid revenue growth, particularly from B2B sales in the post-acute care market. The company is methodically rolling out new capabilities to deliver the industry's first AI-powered EMR platform by Q2 2026, with specific features like billing of care services targeted for November 2025 and two major capabilities in December 2025 and January 2026. Amesite expects to achieve profitability with fewer than 10,000 total B2C and B2B users.

Management Comments

• "Our teams focus on operational discipline has enabled us to drive revenue growth while reducing operating expenses. We are focused on delivering increased value to our shareholders by practicing what we preach: using AI-powered process optimization that continuously increases our business efficiency." Madison Bush, Director of Corporate Operations.
• "Our increased revenue, of 82% and 69% QoQ for the last two quarters, reflects the strong demand from our customers for NurseMagic™s AI-powered platform support. With a strong technology foundation, and relationships built through delivery of value, we believe that we will grow our business with existing customers and also onboard new, larger clients because of our differentiation in technology." Brandon Owens, VP of Sales.
• "The only way to solve the urgent need to increase the efficiency of delivery of U.S. healthcare, while also improving the quality of care, is through innovation. AI will play the most important role in this transition. By methodically rolling out capabilities and services on our proprietary, AI-powered NurseMagic™ platform, we are working to meet the strong demand for end-to-end, AI-enhanced platform support for post-acute care." Dr. Ann Marie Sastry, Founder & CEO.

Industry Context

The announcement positions Amesite at the forefront of leveraging AI to address critical inefficiencies in the U.S. healthcare system, particularly within the rapidly growing post-acute care segment. This segment, encompassing home care, hospice, skilled nursing, and senior living, is expanding at over 8% CAGR, outpacing acute care (6% CAGR), driven by an aging population and increasing chronic diseases. Amesite's NurseMagic™ platform directly tackles the high cost and low efficiency of healthcare documentation, a major pain point, by automating administrative tasks and improving patient care through data leverage. The move towards an AI-powered EMR aligns with the broader industry trend of digital transformation and AI adoption to enhance operational efficiency and quality of care.

Comparison to Industry Standards

• NurseMagic™'s ability to reduce documentation time from 20 minutes to 20 seconds (a 95% reduction) significantly outperforms traditional manual or less integrated digital documentation processes common in the post-acute care sector.
• The company's rapid development and delivery cycle, rolling out 5 to 15 new capabilities each week, suggests a highly agile and efficient development process compared to larger, more entrenched EMR providers who often have slower update cycles.
• Amesite's focus on an AI-powered EMR for post-acute care positions it uniquely, as many established EMR systems are primarily designed for acute care settings (e.g., Epic, Cerner) and may not be as optimized for the specific workflows and data needs of home health, hospice, and senior living.
• The goal of achieving profitability with fewer than 10,000 total users indicates a highly efficient business model and potentially higher average revenue per user compared to many SaaS companies that require much larger user bases for profitability.

Stakeholder Impact

• **Shareholders:** Positive impact due to significant revenue growth, reduced operating expenses, zero debt, and clear strategic direction towards a high-growth market. Management's personal investment signals strong conviction.
• **Employees:** Potential for increased workload and opportunities in a growing company, particularly in AI development and healthcare solutions. The focus on operational efficiency through AI may streamline tasks.
• **Customers (Post-Acute Care Providers):** Highly positive impact through NurseMagic™'s ability to drastically reduce documentation time (95% reduction), improve operational efficiency, and enhance patient care. The upcoming AI-powered EMR promises further integration and benefits.
• **Patients:** Indirect positive impact through improved quality of care resulting from more efficient healthcare delivery and reduced administrative burden on care providers.
• **Suppliers/Partners:** Potential for increased collaboration as Amesite expands its platform capabilities and customer base, particularly those involved in healthcare IT and AI infrastructure.

Next Steps

• Targeting delivery of billing of care services in November 2025.
• Announcing two new major capabilities in December 2025 and January 2026.
• Targeting delivery of the first AI-powered EMR platform for post-acute care by Q2 2026.
• Winning senior living users in Q2 2026.
• Closing the first full EMR customer in Q2 2026.

Key Dates

Recommendation

The filing demonstrates exceptional operational performance with a 69% QoQ revenue increase while simultaneously cutting operating expenses, a rare feat. The company has zero debt and a solid cash position, indicating financial prudence. Its strategic pivot to the high-growth post-acute care market with the innovative NurseMagic™ AI platform, and the clear roadmap to launch the first AI-powered EMR, positions it for significant future expansion. Strong customer testimonials, accelerated engagement, and management's substantial personal investment underscore high conviction and execution capability. These factors collectively suggest a strong growth trajectory and undervaluation potential, making it a compelling 'strong buy'.

Keywords

AI-powered enterprise solutions, NurseMagic, Electronic Medical Record, EMR, post-acute care, healthcare technology, revenue growth, SaaS, HIPAA compliant, digital health, medical documentation, Amesite